LGALS3 and coronary artery disorder: Gal-3 concentration was significantly higher in the CAD and ACS group compared to the control group (mean: 20.72 vs. 10.06 ng/mL, p < 0.00001; 22.94 vs. 10.06 ng/mL, p < 0.00001).